Skip to Main Content

Paper Details

PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate.
Eur Urol
183
2015
Author NameAffiliation
Roberta FerraldeschiThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Susana MirandaThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Zafeiris ZafeiriouThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Joaquin MateoThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Raquel Perez-LopezThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Nina TunariuThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Gerhardt AttardThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Johann S de BonoThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
  • 1 - 8

Datasets